Literature DB >> 24195661

Prophylaxis and post-exposure treatment of intoxications caused by nerve agents and organophosphorus pesticides.

Kamil Kuca, Daniel Jun, Kamil Musilek, Miroslav Pohanka, Jana Zdarova Karasova, Ondrej Soukup1.   

Abstract

Treatment of intoxications caused by nerve agents and organophosphorus pesticides consists of different approaches. The first approach is called prophylaxis or pre-exposure administration of antidotes such as cholinesterase reactivators or bioscavengers. The second, post-exposure treatment consists of anticholinergic drugs, acetylcholinesterase reactivators and anticonvulsants. This article is aimed at both mentioned approaches, especially focused on cholinesterase reactivators, which are a broad group of structurally different compounds that can be used in prophylaxis (separately or in combination with butyrylcholinesterase) and also as post-exposure treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24195661     DOI: 10.2174/13895575113136660108

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  3 in total

1.  A 7-methoxytacrine-4-pyridinealdoxime hybrid as a novel prophylactic agent with reactivation properties in organophosphate intoxication.

Authors:  E Nepovimova; J Korabecny; R Dolezal; T D Nguyen; D Jun; O Soukup; M Pasdiorova; P Jost; L Muckova; D Malinak; L Gorecki; K Musilek; Kamil Kuca
Journal:  Toxicol Res (Camb)       Date:  2016-05-25       Impact factor: 3.524

Review 2.  Novichoks: The Dangerous Fourth Generation of Chemical Weapons.

Authors:  Tanos C C Franca; Daniel A S Kitagawa; Samir F de A Cavalcante; Jorge A V da Silva; Eugenie Nepovimova; Kamil Kuca
Journal:  Int J Mol Sci       Date:  2019-03-11       Impact factor: 5.923

3.  Interaction of Cucurbit[7]uril with Oxime K027, Atropine, and Paraoxon: Risky or Advantageous Delivery System?

Authors:  Jana Zdarova Karasova; Martin Mzik; Tomas Kucera; Zbynek Vecera; Jiri Kassa; Vit Sestak
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.